Webinar 일정: 한국시간 2020년 6월 3일 00:00 AM
한국시간 2020년 6월 3일 00:00 AM
|
1st session (Tue, May 26, 2020 9:00 PM - 10:00 PM KST, 한국시간 5/26 09:00PM) 2nd session (Wed, May 27, 2020 3:00 AM - 4:00 AM KST, 한국시간 5/27 03:00AM) Synthetic peptides are used in a variety of different applications ranging from clinical therapeutics and personalized medicines, to immunoassay screening, antibody production and vaccine design. As peptide chemists strive to achieve new methods and techniques for solid phase peptide synthesis (SPPS), strategies must also be implemented to help reduce the occurrence of unwanted side reactions that inevitability take place during the chemical synthesis process.
This session in the “SPPS Tips for Success” webinar series will focus on side reactions that occur during SPPS and what strategies can be employed to reduce or eliminate these from occurring. Aspartimide formation, racemization, or oxidation can be the thorn in the side of any peptide synthesis project, but how can we identify unwanted side products and what can be done to limit their formation? In this webinar we will discuss preventative measures that can be used depending upon which amino acid residues may be present in the peptide sequence. This session will also cover some side reactions that may occur during cleavage and purification. Whether you are a new or experienced peptide chemist, this webinar will no doubt prove invaluable when designing your next peptide synthesis strategy! Learning Objectives: Understand how to identify unwanted side products that can form during SPPS. Learn how to implement proactive measures to reduce the risk of side reactions occurring. Understand which residues and sequence motifs may be prone to side reactions or degradation. Speaker: Lukasz Frankiewicz PhD, Senior Product Specialist, Gyros Protein Technologies The voltage-gated sodium channels (Nav) subtype Nav1.7 has been genetically validated to be involved in nociception. Join this free webinar to discover how engineering peptides achieves subtype specificity and complete inhibition of specific sodium channels to unlock the potential of potent venom peptides as therapeutic leads for the treatment of pain Topics in this presentation include:
Speaker  Christina I. Schroeder, Stadtman Investigator National Cancer Institute, National Institutes of Health |
RSS 피드